can semaglutide change period and metformin improve menstrual cyclicity in overweight/obese women with polycystic ovary syndrome: a randomized trial Semaglutide cardiovascular outcomes align more

Restore & rebuild function safely: Our team supports you as your body adapts

Discontinuation of GLP-1 receptor agonists before pregnancy or early during pregnancy was tied to more gestational weight and a higher risk for some adverse health outcomes, a study in JAMA Womens Health showed

A network meta-analysis confirmed that adverse events were significantly more frequent with retatrutide (relative risk 4.10) compared to tirzepatide (relative risk 2.78) when both were measured against placebo

Kadohisa M, Rolls ET, Verhagen JV

Some studies suggest that these drugs may help improve fatty liver disease, but more research is needed

The third tier, typified by Goldberg et al